Mondido, Rogelyn G.

HRN: 25-47-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/12/2024
07/19/2024
IV
200mg
Q8hours
T/c Dengue Hemorrhagic Fever
Waiting Final Action 
07/12/2024
CEFTRIAXONE 1G (VIAL)
07/12/2024
07/19/2024
IV
1.8g
Q12hours
T/c Dengue Hemorrhagic Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: